Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Biofourmis Stock

Q: How to sell Biofourmis stock?

If you hold private company shares of Biofourmis - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Biofourmis stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

biofourmis.comHealthcare / Digital HealthFounded: 2018

Biofourmis is a health analytics platform designed to analyze physiology data from clinical-grade wearables. The company's platform uses artificial intelligence to integrate and analyze continuous physiology data from clinical-grade wearables to detect personalized patterns and predict clinical exacerbation in advance of a critical event, enabling medical professionals to intervene days before a critical event and providing better outcomes for patients. Biofourmis utilizes machine learning, integrated biometric data and FDA-cleared analytics to streamline patient care.

Buy or sell Biofourmis stockLearn more about Biofourmis IPO

OverviewFinancingsValuation

Enterprise Value

Access Biofourmis’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Biofourmis.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Biofourmis investors also invested in these private companies

Sequoia Capital India

Insider, Razorpay, Akulaku, Drip Capital, Aspire, Twin, Tabby, Freshworks, Biofourmis, Eruditus

Intel Capital

Figure AI, Scale AI, Volocopter, SambaNova Systems, SiFive, ZeroEyes, Astera Labs, DataRobot, WSO2, Censys

Openspace Ventures

GoJek, Biofourmis

EDBI

Skydance Media, Upside Foods, Beta Technologies, EquipmentShare, Celonis, Bright Machines, Nature's Fynd, Wefox, Trackonomy, Fazz

MassMutual

Prove, Affinity, NYDIG, Mine AI, Aspire, Biofourmis, Ledger Investing

CVS Health Ventures

Abridge, Monogram Health, Redesign Health, Strive Health, Biofourmis

2050 Capital

Biofourmis

Team

Management Team

Kuldeep Singh Rajput

Founder & Chief Executive Officer

Mark Niu

Co-founder & Chief Privacy Officer

Maulik Majmudar, MD

Co-founder & Chief Medical Officer

Milan Shah

Chief Technology Officer

Jaydev Thakkar

Chief Operating Officer

Sheeza Khawar Hussain

Chief Commercial Officer

Matt Borowiecki

Chief Financial Officer

Kirsten Carlson

Chief Marketing Officer

Biofourmis stock FAQs

Can you buy Biofourmis stock?

As Biofourmis is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Biofourmis, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Biofourmis stock?

To invest in a private company like Biofourmis through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Biofourmis stock?

Yes, you may be able to sell your Biofourmis stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Biofourmis stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Biofourmis stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Biofourmis a public company?

No, Biofourmis is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Biofourmis’ stock price?

Biofourmis is a privately held company and therefore does not have a public stock price. However, you may access Biofourmis’ private market stock price with Forge Data.

What is Biofourmis’ stock ticker symbol?

Biofourmis does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Boston Business Journal 09/01/2023

Biofourmis CEO steps down one month after layoffs

The article discusses the recent decision by Alphabet Inc. to spin off its self-driving car unit, Waymo, into a separate entity. The move aims to increase transparency and accountability, and may potentially attract external investment. Waymo's development progress and future strategy are also highlighted.

Fierce Healthcare 09/01/2023

Chutes & Ladders‚Amazon One Medical, Biofourmis among high-profile CEO departures

The CEOs of Amazon One Medical and Biofourmis have announced their departures. COO Trent Green will succeed Amir Dan Rubin at One Medical, following Amazon's acquisition of the primary care provider for $3.9 billion in 2022. Meanwhile, Biofourmis is searching for a new CEO after founder Kuldeep Singh Rajput stepped down. The company also added Ben Wanamaker, former VP of enterprise strategy at Humana, to its board of directors.

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.